Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
BPC-157 is not FDA-approved for any medical condition and is not a controlled substance
Purple Peptides is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, and all products are sold strictly for research purposes only and are not for human or animal consumption.
Patients with Hepatic Impairment Hepatic impairment does not impact the pharmacokinetics of tirzepatide
Peptide Vials (IGF-1 LR3, 1 mg each): 8 weeks 3 vials (~2.24 mg total needed) 12 weeks 4 vials (~3.64 mg total needed) 16 weeks 6 vials (~5.04 mg total needed) Insulin Syringes (U-100, 0.5 mL or 1 mL): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution
J Drug Deliv Ther 8
Repellent effects of aqueous extracts of mustard seeds Brassica juncea , on three major pests of horticultural crops
US$ 24.93
US$ 25.50
US$ 28.95
